XML 146 R109.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Liabilities at FVTPL (Details)
$ / shares in Units, ¥ in Thousands, $ in Thousands
 1 Months Ended 12 Months Ended
Apr. 30, 2021
USD ($)
shares
Dec. 31, 2019
USD ($)
Jun. 30, 2018
CNY (¥)
Jul. 31, 2021
shares
May 31, 2020
shares
Jun. 30, 2018
$ / shares
shares
Dec. 31, 2024
USD ($)
Integer
$ / shares
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2015
CNY (¥)
Financial Liabilities at FVTPL[Line Items]                  
Increased amount | $             $ 91,780  
Preferred shares, par value | $ / shares             $ 0.0001    
Minimum period for qualified IPO             2 years    
Controlling interest, percentage             50.00%    
Threshold period to make remedy after the occurrence of material breach             30 days    
Adlai Hangzhou [Member] | Series A Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Increased amount | ¥                 ¥ 70,000
Adlai Hangzhou [Member] | Series B Convertible Loans [Member] | Series B Onshore Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Total consideration | ¥     ¥ 165,000            
Interest rate           15.00%      
Series A Convertible Preferred Shares [Member] | Adlai Hangzhou [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Converted equity interests           14,560,000      
Preferred shares, par value | $ / shares           $ 0.0001      
Series B Convertible Redeemable Preferred Shares [Member] | Series B Offshore Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Total consideration | $             $ 27,000    
Shares subscribed             6,907,896    
Series B Convertible Redeemable Preferred Shares [Member] | Series C Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Increased amount | $   $ 63,700              
Shares subscribed             14,653,013    
Series B Convertible Redeemable Preferred Shares [Member] | Series D Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Increased amount | $ $ 97,370                
Shares subscribed 14,722,505                
Series B Convertible Redeemable Preferred Shares [Member] | China Equities HK Limited [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Number of shares issued       100,000          
Series B Convertible Redeemable Preferred Shares [Member] | Adlai Hangzhou [Member] | Series B Onshore Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Preferred shares, par value | $ / shares           $ 0.0001      
Series B Convertible Redeemable Preferred Shares [Member] | Adlai Hangzhou [Member] | Series B Convertible Loans [Member] | Series B Onshore Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Convertible loans issued           6,600,000      
Convertible aggregate loan         6,600,000        
Series C and Series D Convertible Redeemable Preferred Shares [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Return on investment             100.00%    
Interest rate on investment per annum             10.00%    
Next Equity Financing Warrant [Member] | Series B Investors [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Preferred shares, par value | $ / shares           $ 0.0001      
Exercise price per share, percentage           95.00%      
Business Objectives [Member]                  
Financial Liabilities at FVTPL[Line Items]                  
Preferred shares percentage             70.00%    
Minimum number of products to be promoted | Integer             3    
Threshold period to promote the products to next clinical stage from closing date             18 months    
Minimum period for qualified IPO             2 years    
Pre-public offering market capitalization | $             $ 650,000    
Vote for ordinary share             1